PrismTcell^™

Considering Abatacept for your RA patients?

PrismTcell™ is a blood-based molecular test developed using Scipher Medicine’s AI-powered Multi-Modal modeling platform to predict patient response to Abatacept.

Healthcare professionals can request information about early-access opportunities and planned availability.

You can see our ACR2026 poster here.

Want to learn more about PrismTcell™?

You can receive study information and early-access updates by email here:

Name(Required)

First name * Last name *

Practice / institution (optional)

Campaign source

Professional role (optional)

Email address *(Required)